InvestorsHub Logo
Followers 246
Posts 2992
Boards Moderated 1
Alias Born 06/16/2015

Re: None

Tuesday, 10/13/2020 6:38:13 PM

Tuesday, October 13, 2020 6:38:13 PM

Post# of 63074
There is no reason for PASO or the DA for the CLX/PASO merger to be mentioned in tomorrow's (https://twitter.com/BeckersHR) conference/webinar by Joey Gonzalez (SiriusIQ/CLX) or anyone else.

Anyone/everyone who knows anything about PASO, CLX or the pending merger knows better than to expect that "we" - meaning PASO the PubCo that CLX is merging with - will be mentioned in this conference/webinar. If that were to happen, it would be a huge surprise.

HOWEVER - CLX via Twitter has stated that "announcements regarding partners and roadmap will follow" (the conference). That is ALL that has been promised for tomorrow. But THAT is a pretty big deal for us, while we are near the deadline for the Tender Offer for Series C shares conversion, as well as being in the same general time frame for the announcement of a signed Definitive Agreement (DA) for the PASO-CLX merger:

https://twitter.com/CLXHealth/status/1313852913886822401

This is not a conference to talk about corporate plans for M&A and such. The following describes what tomorrow's discussion/presentation by industry experts is about, and it's not about hyping or whatever for OTC traders, I guarantee it.

Anyone saying there will be a "big disappointment" if PASO or DA are not mentioned in the conference/webinar are... well, let's say it's probably wishful thinking for a buying opportunity? I know some probably wish they bought more during the recent dip, or that they didn't sell so soon. But hey, anyone can buy shares at the ask price at any time.

https://go.beckershospitalreview.com/data-and-disruptors-three-companies-harnessing-the-positive-power-of-data-during-transformative-times

Data and disruptors: Three companies harnessing the positive power of data during transformative times
Wednesday, October 14th, 2020 | 1:00 pm - 2:00 pm CT
Quality data has the power to drive actionable insights to improve health and wellness of populations and foster industry change for patients, members, employees, businesses and consumers at large. In this session moderated by industry veteran Jim Bohnsack, we’ll hear how trailblazers from Socially Determined, CLX Health and RIP Medical Debt are using data to better understand, engage and improve the lives of their stakeholders. Despite the silos and lack of access equity that exists, the right data coupled with the right technology partners can drive efficiencies, improve wellness outcomes and advance innovation.

Join the discussion to hear how these forward-thinking organizations are:

Identifying social risk attributes in combination with clinical and claims data to create a holistic view of health and social risks in order to help healthcare organizations be more efficient and effective at driving better health outcomes, implementing interventions, deploying resources and measuring the ROI.
Leveraging existing solutions in a unique way to make health status portable and shareable in order to get people back to work in the midst of the COVID-19 pandemic.
Using data to relieve the medical debt of those working on the front lines of the pandemic and those facing financial hardship resulting from the COVID-19-induced economic downturn.

Panelists:
Trenor Williams, MD — Socially Determined
Joseph Gonzalez — CLX Health
Craig Antico — RIP Medical Debt

Moderated by: James C. Bohnsack, TransUnion Healthcare